Meta-analysis finds screening for prostate cancer with PSA does not reduce prostate cancer-related or all-cause mortality but results likely due to heterogeneity - The two highest quality studies identified do find prostate cancer-related mortality reductions

2011-02-01

Evidence-Based Medicine , Volume 16 - Issue 1 p. 20- 21

Additional Metadata
Persistent URL	doi.org/10.1136/ebm1165, hdl.handle.net/1765/31554
Journal	Evidence-Based Medicine
Organisation	Erasmus MC: University Medical Center Rotterdam
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Roobol-Bouts, M., Carlsson, S., & Hugosson, J. (2011). Meta-analysis finds screening for prostate cancer with PSA does not reduce prostate cancer-related or all-cause mortality but results likely due to heterogeneity - The two highest quality studies identified do find prostate cancer-related mortality reductions. Evidence-Based Medicine (Vol. 16, pp. 20–21). doi:10.1136/ebm1165

Publication